These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 28099149)

  • 21. The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer.
    Winter SC; Shah KA; Han C; Campo L; Turley H; Leek R; Corbridge RJ; Cox GJ; Harris AL
    Cancer; 2006 Aug; 107(4):757-66. PubMed ID: 16826581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment.
    Mikkilineni L; Whitaker-Menezes D; Domingo-Vidal M; Sprandio J; Avena P; Cotzia P; Dulau-Florea A; Gong J; Uppal G; Zhan T; Leiby B; Lin Z; Pro B; Sotgia F; Lisanti MP; Martinez-Outschoorn U
    Semin Oncol; 2017 Jun; 44(3):218-225. PubMed ID: 29248133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression.
    Sanità P; Capulli M; Teti A; Galatioto GP; Vicentini C; Chiarugi P; Bologna M; Angelucci A
    BMC Cancer; 2014 Mar; 14():154. PubMed ID: 24597899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism.
    Ullah MS; Davies AJ; Halestrap AP
    J Biol Chem; 2006 Apr; 281(14):9030-7. PubMed ID: 16452478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CAIX forms a transport metabolon with monocarboxylate transporters in human breast cancer cells.
    Ames S; Andring JT; McKenna R; Becker HM
    Oncogene; 2020 Feb; 39(8):1710-1723. PubMed ID: 31723238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression.
    Pinheiro C; Sousa B; Albergaria A; Paredes J; Dufloth R; Vieira D; Schmitt F; Baltazar F
    Histol Histopathol; 2011 Oct; 26(10):1279-86. PubMed ID: 21870331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological Inhibition of MCT4 Reduces 4-Hydroxytamoxifen Sensitivity by Increasing HIF-1α Protein Expression in ER-Positive MCF-7 Breast Cancer Cells.
    Nadai T; Narumi K; Furugen A; Saito Y; Iseki K; Kobayashi M
    Biol Pharm Bull; 2021; 44(9):1247-1253. PubMed ID: 34471053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monocarboxylate transporter 4 involves in energy metabolism and drug sensitivity in hypoxia.
    Yamaguchi A; Mukai Y; Sakuma T; Narumi K; Furugen A; Yamada Y; Kobayashi M
    Sci Rep; 2023 Jan; 13(1):1501. PubMed ID: 36707650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cigarette Smoke Induces Metabolic Reprogramming of the Tumor Stroma in Head and Neck Squamous Cell Carcinoma.
    Domingo-Vidal M; Whitaker-Menezes D; Martos-Rus C; Tassone P; Snyder CM; Tuluc M; Philp N; Curry J; Martinez-Outschoorn U
    Mol Cancer Res; 2019 Sep; 17(9):1893-1909. PubMed ID: 31239287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome.
    Doyen J; Trastour C; Ettore F; Peyrottes I; Toussant N; Gal J; Ilc K; Roux D; Parks SK; Ferrero JM; Pouysségur J
    Biochem Biophys Res Commun; 2014 Aug; 451(1):54-61. PubMed ID: 25058459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of somatic VHL gene mutations in sporadic head and neck paragangliomas in association with activation of the HIF-1α/miR-210 signaling pathway.
    Merlo A; de Quirós SB; de Santa-María IS; Pitiot AS; Balbín M; Astudillo A; Scola B; Arístegui M; Quer M; Suarez C; Chiara MD
    J Clin Endocrinol Metab; 2013 Oct; 98(10):E1661-6. PubMed ID: 23902947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical detection of HIF-1alpha and CAIX in advanced head-and-neck cancer. Prognostic role and correlation with tumor markers and tumor oxygenation parameters.
    Kappler M; Taubert H; Holzhausen HJ; Reddemann R; Rot S; Becker A; Kuhnt T; Dellas K; Dunst J; Vordermark D; Hänsgen G; Bache M
    Strahlenther Onkol; 2008 Aug; 184(8):393-9. PubMed ID: 18956515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulation of the toll-like receptor 3 promotes metabolic reprogramming in head and neck carcinoma cells.
    Veyrat M; Durand S; Classe M; Glavan TM; Oker N; Kapetanakis NI; Jiang X; Gelin A; Herman P; Casiraghi O; Zagzag D; Enot D; Busson P; Vérillaud B
    Oncotarget; 2016 Dec; 7(50):82580-82593. PubMed ID: 27791989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monocarboxylate transporters MCT1 and MCT4 are independent prognostic biomarkers for the survival of patients with clear cell renal cell carcinoma and those receiving therapy targeting angiogenesis.
    Cao YW; Liu Y; Dong Z; Guo L; Kang EH; Wang YH; Zhang W; Niu HT
    Urol Oncol; 2018 Jun; 36(6):311.e15-311.e25. PubMed ID: 29657088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
    Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aerobic exercise-induced HIF-1α upregulation in heart failure: exploring potential impacts on MCT1 and MPC1 regulation.
    Xu L; Yang M; Wei A; Wei Z; Qin Y; Wang K; Li B; Chen K; Liu C; Li C; Wang T
    Mol Med; 2024 Jun; 30(1):83. PubMed ID: 38867145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma - MCT1 as potential target in diffuse large B cell lymphoma.
    Afonso J; Pinto T; Simões-Sousa S; Schmitt F; Longatto-Filho A; Pinheiro C; Marques H; Baltazar F
    Cell Oncol (Dordr); 2019 Jun; 42(3):303-318. PubMed ID: 30790227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIF-1α and CA-IX as predictors of locoregional control for determining the optimal treatment modality for early-stage laryngeal carcinoma.
    Kwon OJ; Park JJ; Ko GH; Seo JH; Jeong BK; Kang KM; Woo SH; Kim JP; Hwa JS; Carey TE
    Head Neck; 2015 Apr; 37(4):505-10. PubMed ID: 24677746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of HIF-1α and CAIX in nasopharyngeal carcinoma and their correlation with patients' prognosis.
    Chen Y; Li X; Wu S; Xu G; Zhou Y; Gong L; Li Z; Yang D
    Med Oncol; 2014 Dec; 31(12):304. PubMed ID: 25377659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear factor E2-related factor-2 has a differential impact on MCT1 and MCT4 lactate carrier expression in colonic epithelial cells: a condition favoring metabolic symbiosis between colorectal cancer and stromal cells.
    Diehl K; Dinges LA; Helm O; Ammar N; Plundrich D; Arlt A; Röcken C; Sebens S; Schäfer H
    Oncogene; 2018 Jan; 37(1):39-51. PubMed ID: 28846107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.